Conference Reports for NATAP

62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back

Single-Dose Pharmacokinetics of Daclatasvir (DCV; BMS-790052) in Subjects With Hepatic Impairment Compared With Healthy Subjects       Reported by Jules Levin AASLD Nov 5 2011 SF   Bifano M,1 Sevinsky H,1 Persson A,2 Chung E,1 Wind-Rotolo M,2 Hwang C,1 Nettles R,1 Grasela D,1 Marbury T,3 DeMicco M,4 Bertz R1 1Bristol-Myers Squibb, Research and Development, Hopewell, NJ; 2Bristol-Myers Squibb, Research and Development, Lawrenceville, NJ; 3Orlando Clinical Research Center, Orlando, FL; 4Advanced Clinical Research Institute, Anaheim, CA